| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/11/1999 | CA2298102A1 Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening |
| 02/11/1999 | CA2297555A1 Collagen-peptide assay method |
| 02/11/1999 | CA2297489A1 Novel bone mineralization proteins, dna, vectors, expression systems |
| 02/11/1999 | CA2296663A1 Bacillus thuringiensis cry6-toxins with improved activity |
| 02/11/1999 | CA2296398A1 5' ests for secreted proteins expressed in endoderm |
| 02/11/1999 | CA2294650A1 Starch debranching enzymes |
| 02/11/1999 | CA2291944A1 Genetic method for controlling sprouting |
| 02/11/1999 | CA2239836A1 Novel arginine deiminase |
| 02/11/1999 | CA2225185A1 Myoblast transfer therapy for relieving pain and for treating behavioral and perceptive abnormalities |
| 02/10/1999 | EP0896063A2 Method for the selection of genetically transformed cells and compounds for use in the method |
| 02/10/1999 | EP0896060A2 RpoA gene from Staphylococcus aureus |
| 02/10/1999 | EP0896059A2 Method for the production of pathogen resistant plants |
| 02/10/1999 | EP0896058A1 Novel semaphorin z and gene encoding the same |
| 02/10/1999 | EP0896055A2 Apoptosis inducing protein and gene encoding the same |
| 02/10/1999 | EP0895543A1 Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens |
| 02/10/1999 | EP0895542A1 Derived tyrosine hydroxylase gene expression system |
| 02/10/1999 | EP0895540A1 Fruit ripening |
| 02/10/1999 | EP0895539A2 Secreted proteins and polynucleotides encoding them |
| 02/10/1999 | EP0895538A1 Mutated ras peptides for generation of cd8?+ cytotoxic t lymphocytes |
| 02/10/1999 | EP0693120B1 Tumoricide t lymphocytes |
| 02/10/1999 | EP0597843B1 16 kDa SURFACE PROTEIN OF P. FALCIPARUM |
| 02/10/1999 | CN1207775A Conditionally replicating viral vectors and their use |
| 02/10/1999 | CN1207772A Modification process |
| 02/10/1999 | CN1207769A Tissue-specific and target RNA-specific ribozymes |
| 02/10/1999 | CN1207768A Nucleic acid molecule encoding 11-cis retinol dehydrogenase |
| 02/10/1999 | CN1207395A Anti-FAS antibodies |
| 02/09/1999 | US5869612 Amino acid sequence of isolated protein involved in post-receptor signal transduction; treatment of rheumatoid arthritis and septic shock |
| 02/09/1999 | US5869610 Isolated polypeptide identified as a cytokine receptor containing extracellular, transmembrane and intracellular domains; prenatal testing and cancer diagnosis |
| 02/09/1999 | US5869463 Use of neuro-glial cell lines for transplantation therapy |
| 02/09/1999 | US5869445 Methods for eliciting or enhancing reactivity to HER-2/neu protein |
| 02/09/1999 | US5869332 Metastatic melanoma cell lines from monodelphis domestica for use in anti-cancer agent discovery |
| 02/09/1999 | US5869313 Dna fragments coding for envelope and regulatory proteins of hiv-1 strains common to united states; for vaccines and detection in blood samples |
| 02/09/1999 | US5869309 Cephalosporin esterase gene from Rhodosporidium toruloides |
| 02/09/1999 | US5869293 DNA encoding human interferon IFN -α001 |
| 02/09/1999 | US5869292 Producing genetically engineered protein by replacing at least one acidic region of factor viii with acidic region of hirudin or heparin cofactor ii; increased coagulant activity |
| 02/09/1999 | US5869290 Cayae1 polynucleotides |
| 02/09/1999 | US5869286 Receptor that binds IL-17 |
| 02/09/1999 | US5869284 Polynucleotide for gene expression in cultures; for tissue regeneration, stimulation of immune and hematopoeitic systems, modulators of receptor activity |
| 02/09/1999 | US5869282 Nucleotide and protein sequences of the serrate gene and methods based thereon |
| 02/09/1999 | US5869281 For culturing and screening for modulators of receptor; glucoma, synchronization of animal estrus cycles, antitumor and antiprolferative agents |
| 02/09/1999 | US5869270 Single chain MHC complexes and uses thereof |
| 02/09/1999 | US5869268 Anti-hanganutzui-deicher human monoclonal igg antibody; for anticarcinogenic and antitumors agents and diagnosis |
| 02/09/1999 | US5869266 Human olfactory neuron cultures to diagnose Alzheimer's disease |
| 02/09/1999 | US5869253 Enzymatic ribozyme molecule having a substrate binding site and an active site that cleaves hepatitis c virus rna; diagnosis and viricides |
| 02/09/1999 | US5869243 Immortalized hepatocytes |
| 02/09/1999 | US5869235 Dna coding for the coat protein of virus isolated from infected vine plants; for detection of vrial infection by reverse transcription polymerase chain reaction and southern blotting |
| 02/09/1999 | US5869230 Gene transfer into the kidney |
| 02/09/1999 | US5869077 Subcutaneously implanting in patient immunoisolatory vehicle comprising core containing living cells which secrete insulin dispersed in biocompatible matrix, surrounded by biocompatible external permselective jacket |
| 02/09/1999 | US5869050 Administering to patient antibody against b7 antigen and immunosuppressive agent in synergistic mixture; treatment of transplant rejection, graft versus host disease, rheumatoid arthritis |
| 02/09/1999 | US5869041 Delivery of bioactive compounds to an organism |
| 02/09/1999 | US5869037 Adenoviral-mediated gene transfer to adipocytes |
| 02/09/1999 | CA1340384C Methode d'utilisation de vecteurs d'expression eucaryotes comprenant un amplificateur du virus bk |
| 02/08/1999 | CA2239223A1 Novel rpoa |
| 02/06/1999 | CA2239256A1 Novel lgt |
| 02/05/1999 | CA2239817A1 Novel prokaryotic polynucleotides, polypeptides and their uses |
| 02/04/1999 | WO1999005527A2 Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens |
| 02/04/1999 | WO1999005502A2 Modulation of multicellular aggregates by solid stress |
| 02/04/1999 | WO1999005301A1 Gene transfer method with the use of serum-free medium |
| 02/04/1999 | WO1999005300A2 Ghrh expression system and methods of use |
| 02/04/1999 | WO1999005297A1 T7 promoter-based expression system |
| 02/04/1999 | WO1999005291A2 Aggrecan degrading metallo proteases |
| 02/04/1999 | WO1999005285A1 Method for producing biotin |
| 02/04/1999 | WO1999005281A1 Novel nucleic acid molecules and uses therefor |
| 02/04/1999 | WO1999005280A1 Mammalian cytokine: interleukin-b30 and related reagents |
| 02/04/1999 | WO1999005275A1 Secreted proteins encoded by human chromosome 13 |
| 02/04/1999 | WO1999005268A1 Production of erythropoietin by endogenous gene activation |
| 02/04/1999 | WO1999005267A1 Identification of human cell lines for the production of human proteins by endogenous gene activation |
| 02/04/1999 | WO1999005264A2 Production of human mutant proteins in human cells by homologous recombination |
| 02/04/1999 | WO1999005262A2 Method for obtaining an epithelial cell sheet |
| 02/04/1999 | WO1999005261A1 Monospecific antibody reactive with matrix metalloproteinase cleavage products of fibrin(ogen) |
| 02/04/1999 | WO1999005255A1 Methods for enhancing or reducing preimplantation embryo survival rates |
| 02/04/1999 | WO1999005174A1 The ha-1 antigen |
| 02/04/1999 | WO1999005173A1 The ha-1 antigen |
| 02/04/1999 | WO1999005171A1 NOVEL ESTROGEN RECEPTOR β AND ISOFORMS |
| 02/04/1999 | WO1999005170A1 NOVEL ESTROGEN β RECEPTOR AND ISOFORMS |
| 02/04/1999 | WO1999004820A2 Cytolysis of target cells by superantigen conjugates inducing t-cell activation |
| 02/04/1999 | WO1999004819A1 Liposomal compositions for the delivery of nucleic acid catalysts |
| 02/04/1999 | WO1999004810A2 Use of mhc class ii ligands as adjuvant for vaccination and of lag-3 in cancer treatment |
| 02/04/1999 | WO1999004775A2 Method of treating dopaminergic and gaba-nergic disorders |
| 02/04/1999 | WO1999004622A1 Transgenic plants with tocopherol methyltransferase |
| 02/04/1999 | WO1999004621A1 A molecular marker for the gene determining the fructose to glucose ratio in mature tomato fruit |
| 02/04/1999 | WO1999004618A1 A method of producing transformed cells of barley |
| 02/04/1999 | WO1998050424A3 Human serine protease precursor |
| 02/04/1999 | DE19732751A1 Neue Beta-Glucanase aus Bacillus New beta-glucanase from Bacillus |
| 02/04/1999 | CA2732570A1 Use of mhc class ii ligands as adjuvant for vaccination and of lag-3 in cancer treatment |
| 02/04/1999 | CA2301166A1 Liposomal compositions for the delivery of nucleic acid catalysts |
| 02/04/1999 | CA2298887A1 The ha-1 antigen |
| 02/04/1999 | CA2298053A1 Novel estrogen receptor .beta. and isoforms |
| 02/04/1999 | CA2298050A1 Transgenic plants with tocopherol methyltransferase |
| 02/04/1999 | CA2298015A1 Production of erythropoietin by endogenous gene activation |
| 02/04/1999 | CA2297907A1 Human estrogen receptor beta |
| 02/04/1999 | CA2297491A1 Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens |
| 02/04/1999 | CA2297410A1 Method of treating dopaminergic and gaba-nergic disorders |
| 02/04/1999 | CA2297381A1 Method for producing biotin |
| 02/04/1999 | CA2297375A1 Ghrh expression system and methods of use |
| 02/04/1999 | CA2297364A1 Novel nucleic acid molecules and uses therefor |
| 02/04/1999 | CA2296798A1 Directed cytolysis of target cells, agents and compositions causing cytolysis, and compounds that can be used to produce the agents |
| 02/04/1999 | CA2296292A1 Secreted proteins encoded by human chromosome 13 |
| 02/04/1999 | CA2239267A1 Novel compounds |
| 02/03/1999 | EP0894866A1 Promoter |